Gene interactions and pathways from curated databases and text-mining
J Leukoc Biol 2005, PMID: 16204634

S6 kinase 2 potentiates interleukin-3-driven cell proliferation.

Cruz, Rebecca; Hedden, Lee; Boyer, Derek; Kharas, Michael G; Fruman, David A; Lee-Fruman, Kay K

Interleukin-3 (IL-3) mediates hematopoietic cell survival and proliferation via several signaling pathways such as the Janus kinase/signal transducer and activator of transcription pathway, mitogen-activated protein kinase (MAPK) pathway, and phosphoinositide-3 kinase (PI-3K) pathway. Mammalian target of rapamycin (mTOR) is one of the downstream targets of the PI-3K pathway, and it plays an important role in hematopoiesis and immune cell function. To better elucidate how mTOR mediates proliferation signals from IL-3, we assessed the role of S6 kinase 2 (S6K2), one of the downstream targets of mTOR, in IL-3 signaling. We show that S6K2 is activated by IL-3 in the IL-3-dependent Ba/F3 cell line and that this is mediated by mTOR and its upstream activator PI-3K but not by the MAPK kinase/extracellular signal-regulated kinase pathway. S6K2 is also activated in primary mouse bone marrow-derived mast cells upon IL-3 stimulation. Expression of a rapamycin-resistant form of S6K2, T388E, in Ba/F3 cells provides a proliferation advantage in the absence or presence of rapamycin, indicating that S6K2 can potentiate IL-3-mediated mitogenic signals. In cells expressing T388E, rapamycin still reduces proliferation at all doses of rapamycin, showing that mTOR targets other than S6K2 play an important role in IL-3-dependent proliferation. Cell-cycle analysis shows that T388E-expressing Ba/F3 cells enter S phase earlier than the control cells, indicating that the proliferation advantage may be mediated by a shortened G1 phase. This is the first indication that S6K2 plays a role in IL-3-dependent cell proliferation.

Document information provided by NCBI PubMed

Text Mining Data

IL-3 ⊣ S6 kinase 2 (S6K2): " To better elucidate how mTOR mediates proliferation signals from IL-3, we assessed the role of S6 kinase 2 (S6K2) , one of the downstream targets of mTOR, in IL-3 signaling "

S6K2 → mTOR: " We show that S6K2 is activated by IL-3 in the IL-3 dependent Ba/F3 cell line and that this is mediated by mTOR and its upstream activator PI-3K but not by the MAPK kinase/extracellular signal regulated kinase pathway "

S6K2 → IL-3: " We show that S6K2 is activated by IL-3 in the IL-3 dependent Ba/F3 cell line and that this is mediated by mTOR and its upstream activator PI-3K but not by the MAPK kinase/extracellular signal regulated kinase pathway "

S6K2 → PI-3K: " We show that S6K2 is activated by IL-3 in the IL-3 dependent Ba/F3 cell line and that this is mediated by mTOR and its upstream activator PI-3K but not by the MAPK kinase/extracellular signal regulated kinase pathway "

mTOR → IL-3: " We show that S6K2 is activated by IL-3 in the IL-3 dependent Ba/F3 cell line and that this is mediated by mTOR and its upstream activator PI-3K but not by the MAPK kinase/extracellular signal regulated kinase pathway "

IL-3 → PI-3K: " We show that S6K2 is activated by IL-3 in the IL-3 dependent Ba/F3 cell line and that this is mediated by mTOR and its upstream activator PI-3K but not by the MAPK kinase/extracellular signal regulated kinase pathway "

Manually curated Databases

No curated data.